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Abstract: Cas3 has essential functions in CRISPR immunity but its other activities and roles, in vitro
and in cells, are less widely known. We offer a concise review of the latest understanding and
questions arising from studies of Cas3 mechanism during CRISPR immunity, and highlight recent
attempts at using Cas3 for genetic editing. We then spotlight involvement of Cas3 in other aspects of
cell biology, for which understanding is lacking—these focus on CRISPR systems as regulators of
cellular processes in addition to defense against mobile genetic elements.
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1. Introducing Cas3—The Identification of a DNA Helicase-Nuclease Machine
In this article, we review original research that describes the structure and function of prokaryotic
Cas3. Cas3 is an essential component of CRISPR-Cas adaptive immunity systems that repel invader
genetic elements (reviewed recently [1–3]), but it also plays-in to several other aspects of cell biology,
highlighted in Figure 1. Cas3 is an ATP-dependent single-strand DNA (ssDNA) translocase/helicase
that in many CRISPR systems is fused to a HD-nuclease domain. The Cas3 translocase and nuclease
activities degrade DNA by reducing it to shorter fragments of 10s of nucleotides, nullifying invader
DNA as part of processes called ‘CRISPR interference’.
Cas3 structure and function is described in detail further on. Cas3 was first highlighted in 2002
during in silico analyses of prokaryotic genomes [4,5] that identified its superfamily-2 helicase motifs
(as ‘COG1203’) [4], and its association with other proposed nucleic acid processing enzymes located
alongside repeat DNA sequences [5].
This created the term ‘CRISPR’, for the DNA repeats, and the protein COG1203 became ‘Cas3’,
a CRISPR-associated protein [5]—the discovery and establishment of CRISPR biology and biotechnology
is described in [6]. A subsequent hypothesis proposed that Cas3 is part of an RNA-interference-based
prokaryotic immunity system, ‘CRISPR-Cas’ [7], affirmed in a CRISPR system lacking Cas3 [8]—this
particular system instead uses Cas9 for CRISPR interference reactions—but the importance of Cas3 was
identified in Escherichia coli, functioning in CRISPR immunity with a ‘Cascade’ protein complex [9].
Genes 2020, 11, 208; doi:10.3390/genes11020208 www.mdpi.com/journal/genes
Genes 2020, 11, 208 2 of 14Genes 2020, 11, 208 2 of 14 
 
 
Figure 1. A summary of Cas3 as covered in this review. A. The main events in CRISPR-Cas systems 
that use Cas3. DNA from a mobile genetic element (bacteriophage shown here) is captured and 
integrated into a CRISPR locus by “Adaptation”, catalyzed by Cas1-Cas2 proteins helped by various 
non-Cas host proteins. Transcription of CRISPR generates RNA that after further processing is called 
CRISPR RNA (crRNA) that is loaded into a multi-protein effector complex, forming “Cascade”, 
which targets crRNA to the invader DNA. Cascade recruits Cas3 to targeted DNA forming the 
“Interference” complex that degrades DNA and in so doing can provide DNA for capture by 
Cas1-Cas2. We highlight Cas3 within the interference complex, leading into part B., illustrating that 
studies of Cas3 enzymology in vitro have detailed Cas3 mechanism when associated with Cascade 
and in isolation. Genetic analyses of the cas3 gene and its regulation in bacteria (e.g., by HtpG and 
H-NS) provoke ideas for additional roles of Cas3 in natural cellular physiology and in biotechnology. 
In the figure we highlight experimental observations that indicate potential roles for Cas3 in RNA 
processing and biofilm formation, and usefulness in genetic editing reactions. 
2. Cas3 in CRISPR Immunity—a Cut, Catch, and Reel Mechanism 
Cas3 is a ‘signature’ protein of Type 1 CRISPR systems—classification and evolution of CRISPR 
systems is reviewed in [10–13]. In these systems Cas3 functions with a ribonucleoprotein complex 
called ‘Cascade’. Cascade base pairs CRISPR RNA (crRNA—one per Cascade) to a target DNA 
forming an R-loop [9,14–17]. Recruitment of Cas3 to a Cascade-R-loop therefore places Cas3 DNA 
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nuclease-translocase activity in readiness for degradation of the target DNA. This is the overall basis of
CRISPR interference in Type 1 CRISPR systems.
Diversity of Cascade-Cas3 form and function across Type 1 CRISPR systems is made explicit
by the seven or eight subtypes; 1-A to F, 1-U and 1-Fvariant [13]. Within these, Cascade complexes
vary in composition from three to five protein subunits—although Cas5 and Cas7 are common
to all subtypes—and show some corresponding variation in catalytic functions of the subunits
during genesis of the crRNA payload and its targeting to DNA. Compare, for example, Cascade
complexes from Desulfovibrio vulgaris (subtype 1-C) and E. coli (subtype 1-E) [14,18]. For Cas3 the
most remarkable differences between subtypes are existence of Cas3 fusion and fission proteins.
Fused Cas3 translocase-HD-nuclease proteins are fused further to the Cas2 adaptation enzyme in
some Yersinia and Pseudomonas bacteria. In some archaea Cas3 functions are split into distinct
HD-nuclease and translocase/helicase proteins that are encoded from different genes (respectively,
Cas3” and Cas3’) [19,20] (and authors’ unpublished data). In some cyanobacteria Cas3” is fused to
Cas10d protein [13]. We next assess Cas3 catalytic activities, focusing on the most common form as a
fused HD-nuclease-translocase.
2.1. Cas3 Nuclease
Cas3 comprises a HD-nuclease domain fused to two RecA-like domains characteristic of
superfamily-2 helicases (Figure 2). These co-operate to deliver ATP-dependent ssDNA translocation
and degradation [21,22]. Several conserved features of Cas3 enzymes are likely to be important
for co-ordination of ssDNA from RecA domains into the HD-active site, including a prominent
solvent-exposed helix (labeled ACH in Figure 2A), and tyrosine/tryptophan residues located at the
RecA-HD domain interface and elsewhere. In common with many helicases, Cas3 has an accessory
domain positioned at the protein C-terminus, although its exact functions are not clear. HD-nuclease
function can be supported by a variety of metal ions [19,22,23]. Crystal structures of Cas3 display
HD-active sites bound to iron [24], manganese [25] and calcium (unpublished, PDB code—3M5F,
2011). Biochemistry of Cas3 in vitro indicates nuclease activity stimulated by manganese and cobalt,
and inhibited by iron [23,26], and cobalt was necessary to observe stable interaction between Cas3 and
Cascade in one system at least [27,28].
Critical to the effectiveness of Cas3 as a nuclease in CRISPR systems is that Cascade first validates
a bona fide target DNA. Cascade identifies a DNA ‘PAM’ sequence (‘Protospacer Adjacent Motif’) at
a target site, followed by stabilized DNA binding from RNA-DNA base-pairing, forming a Cascade
R-loop that is ‘locked’ on to the target DNA [27,29–31]. In this state conformation of the Cse1
component of Cascade reveals Cas3 interacting regions. Cas3 will load onto the ssDNA that is
generated in R-loops, but interaction with the Cse1 subunit of Cascade channels its nuclease activity
for CRISPR immunity [18,31–33]. Analysis using Hydrogen-Deuterium Exchange (HDX) coupled to
mass spectrometry identified alpha helix H1 of Cse1 as a critical docking and/or activation site for
interaction with Cas3 [34], and may be the molecular trigger for degradation of targeted DNA by the
Cas3 HD-nuclease activity [27,28].
Biochemical and structural analyses of Cas3 and Cas3-Cascade from E. coli, Thermobaculum
terrenum and Thermobifida fusca have provided exciting evidence about their CRISPR interference
mechanism. In particular, how target DNA is located by Cascade for R-loop formation, how this
engages with Cas3 HD-nuclease and SF2 helicase domains, and how the >500 kDa bulk of Cas3-Cascade
complex translocates ssDNA. All of these bacteria use a Cascade of five protein subunits, Cas5, 6, 7, 8e
(Cse1) and Cse2, previously called CasA-E. DNA nicking by the Cas3 HD-nuclease is directed to the
non-targeted DNA strand (NTS) in the R-loop, which forms a displaced ssDNA ‘loop’. Exactly how
this is achieved is not clear. Association of Cas3 with the Cse1 subunit of Cascade places the Cas3 HD
site distal to the NTS, although a bulge in NTS DNA caused by Cse1 binding might account for this,
loading Cas3 on ssDNA HD-first. In this scenario the initial HD-nuclease nicking of ssDNA by Cas3
bypasses the SF2 helicase domains. In cryo-EM analyses [26,35] this is sufficient to re-locate ssDNA
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to a position much closer to the RecA domains that power the ATP-dependent translocation of Cas3
along ssDNA. An arginine rich channel (ARC), comprising arginine residues that are highly conserved
in Cas3 proteins across species, apparent in Cas3 structures (Figure 2) may aid stable ‘capture’ of the
ssDNA to initiate translocation.Genes 2020, 11, 208 4 of 14 
 
 
Figure 2. Cas3 structure-function. A. PHYRE2-predicted Escherichia coli Cas3 structure, modeled 
from Cas3 structures solved from Thermobaculum terrenum (PDB 4Q2C) and Thermobifida fusca (PDB 
4QQW, 4QQX and 4QQY), represented in two orientations and with a corresponding cartoon of 
primary sequence presented below. We highlight the HD domain (purple), two RecA-like domains 
(green and orange) and the accessory C-terminal domain (CTD, pale blue). Active sites comprising 
the Asp-His HD domain and the amino acid DEVH motif of one RecA-like domain for 
ATP-hydrolysis are highlighted in red spheres within the structures, and marked on the cartoon 
primary structure. Also marked are the prominent solvent-exposed alpha helix (ACH) and an 
arginine rich channel (ARC) described in the main text. B. Panels should be followed from top left, 
clockwise. The location of Cas3 (using same domain colors as used in part A) bound to Cascade 
subunit protein Cse1 (grey), presented from the T. fusca Cascade-Cas3 structure (PDB: 6C66). DNA 
parts of the R-loop are colored orange—in CRISPR interference this DNA is nicked by the Cas3 HD 
domain, and then assimilated into the translocase/helicase active sites, possibly via interaction 
between DNA and the arginine residues of the ‘ARC’, highlighted as blue spheres. Captured 
single-strand DNA (ssDNA) is then translocated through the Cas3 protein by a reeling mechanism, 
which is associated with nuclease activity that generates DNA fragments. 
Biochemical and structural analyses of Cas3 and Cas3-Cascade from E. coli, Thermobaculum 
terrenum and Thermobifida fusca have provided exciting evidence about their CRISPR interference 
mechanism. In particular, how target DNA is located by Cascade for R-loop formation, how this 
Figure 2. Cas3 structure-function. A. PHYRE2-predicted Escherichia coli Cas3 structure, modeled from
Cas3 structures solved from Thermobaculum terrenum (PDB 4Q2C) and Thermobifida fusca (PDB 4QQW,
4QQX and 4QQY), represented in two orientations and with a corresponding cartoon of primary
sequence presented below. We highlight the HD domain (purple), two RecA-like domains (green
and orange) and the accessory C-terminal domain (CTD, pale blue). Active sites comprising the
Asp-His HD domain and the amino ac d DEVH motif of o e RecA-like domain for ATP-hydrolysis are
highlighted in red spheres within the struc ures, and marked on the cartoon primary structure. Also
marked are the prominent solvent-exposed alpha helix (ACH) and an arginine rich channel (ARC)
described in the main text. B. Panels should be followed from top left, clockwise. The location of
Cas3 (using same domain colors as used in part A) bound to Cascade subunit protein Cse1 (grey),
presented from the T. fusca Cascade-Cas3 structure (PDB: 6C66). DNA parts of the R-loop are colored
orange—in CRISPR interference this DNA is nicked by the Cas3 HD domain, and then assimilated into
the translocase/helicase active sites, possibly via interaction between DNA and the arginine residues of
the ‘ARC’, highlighted as blue spheres. Captured single-strand DNA (ssDNA) is then translocated
through the Cas3 protein by a reeling mechanism, which is associated with nuclease activity that
generates DNA fragments.
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2.2. Cas3 Translocase/Helicase in a CRISPR Interference Machine
Cas3 loads onto ssDNA and translocates it using ATP-hydrolysis [36]. In this way it can separate
DNA duplex strands as a helicase, and may also be able to displace other DNA binding proteins
during translocation, similarly to other translocases [36–39]. After initial DNA nicking by Cas3
HD-nuclease, Cas3 translocates DNA with 3’ to 5’ directionality generating ssDNA gaps from a
Cascade-R-loop formed on duplex DNA, which is detectable in single-molecule experiments using
GFP-RPA [27]. Single-molecule studies of Cas3 from E. coli and T. fusca show translocation over
thousands of nucleotides at mean velocities of 89-316 bp/s [27,40]. E. coli Cas3 was found to rapidly
translocate away from Cascade, while Cascade remained bound to the target site. In this system the
interaction of Cas3 with Cascade, and its subsequent translocation away from Cascade, nucleolytically
destroys the substrate (ssDNA) onto which Cas3 loads at the target site, such that no re-association of
Cas3 and that same Cascade was observed [27,41]. However, when T. fusca Cas3-Cascade was used
half of the translocating Cas3 molecules remained associated with Cascade [40]. In this system it is
proposed that sustained association of Cas3-Cascade remains essentially fixed in place, as DNA moves
relative to it by ‘reeling’ or ‘looping’ powered by ATP-dependent ssDNA translocation of Cas3 [28,40].
The dissociation of T. fusca Cas3 from Cascade then resulted in Cascade re-binding to DNA target
sites. Reeling of NTS DNA through Cas3 resembles mechanisms of DNA translocation by the DNA
replication-recombination-repair helicases PcrA and RecBCD (among others), although with significant
differences in DNA translocation velocity and step-size.
DNA targeting by Cascade is pivotal for Type 1 CRISPR systems because it triggers the destructive
catalysis of Cas3. Initial collision of Cascade complexes with DNA then requires transfer to target
sites that are defined by a trinucleotide PAM sequence—5’-AAG in E. coli—that will direct Cascade
to ‘lock-on’ to DNA if there is complementary crRNA-DNA sequence for R-loop formation. Target
site identification follows biophysical principles established for other site-specific DNA targeting
enzymes, which are conceptualized or described in several possible ways—the reader is directed to two
references in particular, [42,43], for interesting and accessible accounts of these processes. For Cascades,
there are currently some areas of disagreement arising from analyses of target site recognition. In TIRF
and FRET studies, E. coli Cascade favored 3-dimensional (3-D) diffusion to sample physical space for
DNA target sites, analogous to it ‘jumping’ at DNA [27,44]. On sensing a PAM this Cascade dwells to
establish if R-loop formation is possible by RNA-DNA base-pairing. In this model the PAM allows
Cascade to discern kinetically whether the DNA is a bona fide target, or not—summarized in Figure 6 of
reference [44]. A similar study using T. fusca Cascade favored facilitated diffusion of Cascade over
1-dimension (1-D) [40], in which Cascade essentially ‘slides’ or ‘hops’ along DNA while determining
target sites. This also highlighted the importance to the process of five conserved lysine/arginine amino
acid residues within the Cascade structure, which is contrasted with E. coli Cascade in which three
of these five residues are present, a possible factor explaining the discrepancy in behaviors of these
two Cascades. Another factor could be that analysis of the 1-D target site search by T. fusca used DNA
that lacked an identifiable RNA-DNA sequence complementarity that would allow R-loop formation,
despite PAMs being present. In any event, successful engagement of Cascade with DNA target recruits
the Cas3 translocase-nuclease.
2.3. Cas3 Translocase/Nuclease in a CRISPR Interference-Adaptation Machine
DNA reeling by PcrA displaces RecA protein from DNA during DNA replication-repair [45],
giving precedence to a possible role for Cas3 reeling in removing bound proteins during CRISPR
interference reactions. This aspect of Cas3 is particularly interesting—biophysical data indicates that
T. fusca Cas3 and Cas3-Cascade are ineffective at removing ectopic protein ‘roadblocks’ from DNA,
including RNA polymerase barriers [40] that are most relevant to bacterial chromosome dynamics [46].
However, addition of the CRISPR adaptation complex Cas1-Cas2 to Cas3-Cascade, forming a new
machine called the Primed Adaptation Complex (PAC) triggered displacement of RNA polymerase 63%
of the time [40]. In this system it is not known if association of Cas1-Cas2 activates the motive power
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of Cas3 as a DNA translocase, or if Cas1-Cas2 itself modifies some aspect of the PAC or the roadblock
to facilitate its displacement. In Pseudomonas the nuclease activity of the fused Cas2-Cas3 protein
is inhibited strongly by association with Cas1, but this effect is counteracted when the Cas1-Cas2/3
complex encounters Cascade (called ‘Csy’ in this system) that is bound to a target DNA [47].
Physical and functional interaction of the T. fusca PAC and Cas1-Cas2/Cas3/Cascade more generally
in other systems provides the important biological role linking interference with DNA fragment capture
and integration reactions of ‘adaptation’—recently reviewed [48–50]. Physical and functional coupling
of interference with adaptation in a PAC can re-cycle DNA from invader into CRISPR loci, updating
immunity in ‘primed’ or ‘targeted’ adaptation [51–59]. FRET measurements indicated that Cas3 DNA
reeling is stimulated by Cascade but that Cas3 nuclease activity is weak, when compared to nuclease
activity recorded from bulk/ensemble biochemical assays [28]. However, in this study there were no
measurements made of the PAC, by addition of Cas1-Cas2. It would be useful to determine if nuclease
activity within the PAC is stimulated relative to Cas3-Cascade and, if so, whether this is attributable
to Cas3, Cas1-Cas2, or both—there is data suggesting that Cas1-Cas2, and Cas2 alone, have nuclease
activity [60–62]. This would help to understand further the molecular events that underpin the various
stages of primed adaptation.
3. Characteristics of Cas3-Cascade Used for Genetic Editing
The critical importance of Cas3-catalyzed DNA destruction for the functioning of natural CRISPR
systems [9,21] is also highlighted in its manipulation for genetic editing reactions. By deleting Cas3
from E. coli cells (∆cas3) it has been possible to steer Cascade alone to DNA targets for non-destructive
gene repression, targeting ectopic reporter genes (e.g., GFP) or native genes [63]. Bacterial Cas3 has
been used alongside Cascade in various human cell types, giving ‘proof-of-principle’ that Cas3-Cascade
is functional for targeted genetic insertions or deletions (‘indels’) when delivered into cells as proteins
with nuclear localization signals, or expressed endogenously [64–66]. One encouraging trait arising
from Cascade-Cas3 editing reactions, if compared with Cas9, is the low rate of off-target effects
observed in a study using T. fusca Cascade-Cas3 [64], attributed to the stringency by which Cascade
interrogates DNA for a target, and the requirement for it to ‘lock-on’ to the DNA target before Cas3
can be recruited to start its nuclease rampage. In human embryonic stem cells it was reported that the
editing efficiency—reported by disruption of green fluorescent protein (GFP) maximally at 13%—was
determined by available Cascade molecules and was unaffected by increasing availability of Cas3 [64].
These reports indicate the emergence of Cascade as a valuable method for targeted genome-editing,
offering advantages over simpler Cas9/Cas12 editing enzymes that override the disadvantage of
Cascade’s multi-subunit structure. The diversity of Cascades available from natural sources offers
many opportunities for fine-tuning Cascade for this purpose. For example, a study using different
Cascades fused to FokI restriction endonuclease identified that DNA targeting and editing efficiency
was several-fold more effective if the Cascade used in human U20S, HEK293 or HeLa cells was from a
Pseudomonas species rather than from other bacteria [66].
In each of these genome-editing studies Cas3 has generated large regions of genetic deletion,
meeting expectations arising from knowledge of its mechanism and catalytic power. Deletions of up
to 200 kb were reported from T. fusca Cas3-Cascade when expressed from genes in human HEK293
cells [66], and similar sized deletions were observed from E. coli Cas3-Cascade, also expressed from
transfected DNA constructs [65]. In the latter study Cascade-Cas3 was successful at achieving an ‘exon
skipping’ reaction targeted to human dystrophin encoding gene, reactions thought to have potential as
a therapeutic treatment for muscular dystrophies [67]. The ability of Cascade-Cas3 to catalyze high
stringency-high throughput DNA deletion within human cells is a useful new tool to understand large
chunks of the genome.
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4. Interaction of Cas3 with HtpG and Other Host Proteins That Are Not Part of CRISPR Systems
A genome-wide protein interaction study using >4000 immobilized E. coli proteins identified seven
proteins that physically interacted with hexahistidine tagged Cas3 (at that time called YgcB) [68]; GroL,
DnaE, GyrA, AceE, IbpA, CrfC, and MdoD each co-eluted with Cas3 immobilized on Ni-NTA beads.
More generally across bacteria and archaea, functional interactions of CRISPR systems with DNA
repair systems are important for efficient functioning of CRISPR immunity, especially for adaptation
reactions that build CRISPR loci from captured invader or host DNA fragments [61,69–73].
Stable functioning of Cas3 as an essential part of CRISPR immunity processes requires co-expression
of a chaperone protein HtpG in E. coli and probably in other bacteria [74], although HtpG is not widely
distributed across archaea. Functional interaction between Cas3 and HtpG is observed in vivo; CRISPR
immunity against lysogenization by λ prophage at 32 ◦C was lost when HtpG was lacking (∆htpG),
an effect suppressed by Cas3 over-expression. The efficacy of the CRISPR immunity against λ phage
infection is also temperature-dependent—cells lacking HNS protein (∆hns) that are engineered to
target λ phage are effective at resisting infection at 30 ◦C but not 37 ◦C (Figure 3), but cells lacking
HtpG and HNS are phage-sensitive. Over-expression of Cas3 or HtpG rescued this phage sensitivity,
but only at 30 ◦C—the same cells remained sensitive at 37 ◦C [75]. The reason for Cas3 instability in
∆hns cells at 37 ◦C is not known, but may be useful in revealing other roles for Cas3 in cells, and it will
help to have a better understanding of the molecular basis for interaction between Cas3 and HtpG.
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Figure 3. Temperature-dependent Cas3/CRISPR functions in E. coli and the E. coli Δhns strain. 
A.—Cas3 stimulates uncontrolled ColE1 plasmid replication in a temperature-dependent manner. 
ColE1 plasmid yield was stimulated by Cas3 in cells at 37 °C but not at 30°C. This requires a 
functional helicase domain. We speculate that this phenomenon may indicate a possible change in 
Cas3 conformational ‘state’, illustrated by coloring Cas3 in blue ‘demotivated’ or red ‘motivated’. At 
37 °C, ‘motivated’ Cas3 may interact with R-loop formation in ori by dissociating RNA II from the 
complementary strand, and lead to increased plasmid replication in vitro. B.—Temperature impacts 
CRISPR function in E. coli cells lacking H-NS. This Δhns strain at 30 °C can defend against invader 
DNA during phage infection, even though Cas3 is in ‘unmotivated’ state. However, Δhns strain 
cannot survive under infection pressure at 37 °C. 
5. UnPACking of Cas3 from Cascade—Activities with RNA  
An interesting set of observations has been made implicating Cas3 in several other cellular 
events that center on, or are at least associated with, regulatory processing of RNA molecules. In one 
example, ectopic over-expression of Cas3 in E. coli cells stimulated uncontrolled DNA replication of 
plasmids from their ColE1 replicons, but had no such effect on non-ColE1 plasmids [76]. These 
plasmids use R-loop at ori to initiate replication formed by plasmid encoded RNA molecules, one 
that primes replication (RNAII) and the other that prevents priming (RNAI) [77]. Cas3 stimulates 
priming of replication, dependent on its ATPase/translocase activity independently of Cascade [76]. 
It is proposed that Cas3 can specifically target RNAI-RNAII molecules for dissociation, liberating 
RNAII to pair with DNA at ori and priming replication. This unusual property of Cas3 to stimulate 
uncontrolled plasmid replication has been shown to be temperature-dependent, increased at 37 °C 
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Purified Cas3 from E. coli and the archaeal species Methanothermobacter thermautotrophicus can 
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family [79–81], Cas3 can anneal nucleic acid strands as well as unwind them—purified Cas3 is 
especially robust at annealing RNA strands into plasmid DNA (i.e., R-loop formation) [82]. This 
activity required the Cas3 HD domain but is independent of ATPase activity—HD 
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stimulates uncontrolled ColE1 plasmid replication in a temperature-dependent manner. ColE1 plasmid
yield was stimulated by Cas3 in cells at 37 ◦C but not at 30 ◦C. This requires a functional helicase
domain. We speculate that this phenomenon may indicate a possible change in Cas3 conformational
‘state’, illustrated by coloring Cas3 in blue ‘demotivated’ or red ‘motivated’. At 37 ◦C, ‘motivated’ Cas3
may interact with R-loop formation in ori by dissociating RNA II from the complementary strand, and
lead to increased plasmid replication in vitro. B. Temperature impacts CRISPR function in E. coli cells
lacking H-NS. This ∆hns strain at 30 ◦C can defend against invader DNA during phage infection, even
though Cas3 is in ‘unmotivated’ state. However, ∆hns strain cannot survive under infection pressure at
37 ◦C.
5. UnPACking of Cas3 from Cascade—Activities with RNA
An interesting set of observations has been made implicating Cas3 in several other cellular events
that center on, or are at least associated with, regulatory processing of RNA molecules. In one example,
ectopic over-expression of Cas3 in E. coli cells stimulated uncontrolled DNA replication of plasmids
from their ColE1 replicons, but had no such effect on non-ColE1 plasmids [76]. These plasmids use
R-loop at ori to initiate replication formed by plasmid encoded RNA molecules, one that primes
replication (RNAII) and the other that prevents priming (RNAI) [77]. Cas3 stimulates priming of
replication, dependent on its ATPase/translocase activity independently of Cascade [76]. It is proposed
that Cas3 can specifically target RNAI-RNAII molecules for dissociation, liberating RNAII to pair with
DNA at ori and priming replication. This unusual property of Cas3 to stimulate uncontrolled plasmid
replication has been shown to be temperature-dependent, increased at 37 ◦C and decreased at 30 ◦C
(Figure 3). Reduced or inhibited ATPase/helicase activity of Cas3 at 30 ◦C was found responsible for
this effect, and ∆hns mutation was found to indirectly decrease plasmid copy number at 30 ◦C [78].
Purified Cas3 from E. coli and the archaeal species Methanothermobacter thermautotrophicus can
manipulate RNA molecules in vitro. In common with helicase/translocase enzymes of the RecQ
family [79–81], Cas3 can anneal nucleic acid strands as well as unwind them—purified Cas3 is
especially robust at annealing RNA strands into plasmid DNA (i.e., R-loop formation) [82]. This
activity required the Cas3 HD domain but is independent of ATPase activity—HD domain-catalyzed
nicking of DNA is thought to facilitate RNA-DNA annealing by relaxing plasmid supercoiling. It
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is difficult to interpret what specific role this in vitro activity of Cas3 may have in cells, if any, but
it does support ideas that Cas3 may transmit RNA signals into cellular networks more widely than
CRISPR systems. Analysis of the organization of the E. coli MG1655 CRISPR-Cas system identified a
promoter, ‘anti-Pcas’, located just downstream of the cas3 gene coding sequence (see Figure 1B), and
which generates detectable RNA transcript of 150–200 nucleotides [83] that would overlap with the
cas3 transcript. The authors of that study predict that the anti-Pcas transcript may form an elaborate
folded structure, which is reminiscent of riboswitches and other regulatory RNAs. The significance of
this, and any role for Cas3 in its putative function, is not known.
Regulatory roles for CRISPR systems are identified in several contexts [84–86]. The DNA targeting
capabilities of Cascade, and observations that CRISPR systems frequently capture ‘self’ DNA from
host chromosomes as well as ‘non-self’ invader DNA, indicate that CRISPR systems may regulate gene
function as transcription factors [87,88]. Cascade gene targeting has been used for ectopic control of
gene expression [89,90]. Cas3 influences group behavior of Pseudomonas cells—formation of biofilms is
inhibited in response to lysogeny by phage DMS3, a response that requires Cas3 to be fully functioning
for HD-nuclease and helicase activities [91]. In these cells chromosomal sequences partially match
sequences of DMS3 that might allow binding of Cascade that is sufficient to trigger the DNA nicking
step of Cas3 and some ssDNA formation at the Cascade target site. In this model the ssDNA generated
may be enough to trigger the loading of the DNA recombinase RecA, triggering a DNA-repair “SOS”
response that is known to be able to block biofilm formation [92].
As would be expected for the ‘arms-race’ between viruses and their hosts, the crucial roles for
Cas3 in CRISPR immunity and suppressing biofilm formation have driven evolution of inhibitors,
which in Pseudomonas virus JBD5 is AcrF3 protein [93,94]. The molecular details of interaction between
AcrF3 and Cas3 are fascinating, explaining how the inhibitor switches off Cas3 function, informed by
the detailed analyses of Cas3 structure-function, in isolation and in association with Cascade and in
the PAC. There is likely to be plenty more to learn about Cas3 function as a nuclease, translocase, and
possibly as an RNA processing enzyme.
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